Latest Nzx Listings News

Rua Bioscience has raised approximately NZ$1.0 million through its rights offer, well short of the NZ$2.8 million sought. The medicinal cannabis company says it still needs more working capital to fund inventory for its UK expansion.

Enprise Group’s revenue rose 6% in FY2026, but a sharp earnings deterioration, tight liquidity and an auditor-highlighted going concern uncertainty have left its recovery plan dependent on cost cuts and fresh funding. The NZX-listed software group is targeting a return to profitability in FY2027 after refinancing and restructuring its largest business.

Iperion reported a lower loss for the year ended 31 March 2026, but its cash reserves and net assets fell sharply, leaving the NZX-listed materials company reliant on related-party funding and director support. Its Pathoglaze manufacturing operation is also being moved from Malaysia to Singapore while customer trials continue.

Hallenstein Glasson delivered a sharp lift in FY2026 profit as sales, margins and Australian trading strengthened. The NZX-listed retailer also raised its full-year dividend to 69 cents per share, while warning that early FY2027 sales growth is unlikely to persist at the same pace.

Delegat Group delivered record operating earnings and cash flow in FY26, but reported profit fell after a NZ$8.7 million impairment and other fair-value adjustments. The NZX-listed wine company is forecasting higher case sales and operating NPAT of NZ$62 million to NZ$66 million for FY27.

Barramundi Limited (NZX:BRM) has reported the worst performance in its 20-year history, with a NZ$42.9 million net loss and a 17.0% fall in gross portfolio performance. The board is reviewing Fisher Funds’ management performance just weeks before its five-year agreement comes up for renewal.

Synlait’s operational recovery gathered pace in the second half, but the NZX-listed dairy processor still reported a NZ$75.4 million FY26 loss and negative operating cash flow. KPMG flagged a material uncertainty over going concern as the company prepares to refinance facilities due in 2027.

Barramundi’s portfolio surged in August, delivering a 6.7% adjusted NAV return against a 1.9% benchmark gain. The recovery leaves the NZX-listed investment company trading at a 13.2% discount to its underlying portfolio value.

Winton Land has named Michael Stiassny as its new independent chair, stepping into a leadership role during a period of significant board and executive change. The company is actively recruiting additional independent directors and senior executives to stabilise governance and operations.

WasteCo Group has initiated a $2 million share placement at $0.007 per share to fund its ambitious turnaround and growth strategy amid a FY 2026 loss. A Share Purchase Plan will follow, offering existing investors a chance to participate on the same terms.

Julian Cook has resigned as an executive director of Winton Land, citing fundamental disagreements with the majority shareholder on board roles and governance, following similar departures by other directors.

Winton Land’s governance is under strain after independent directors Steven Joyce and Guy Fergusson resigned citing conflicts with the majority shareholder. The board must urgently appoint new independent directors to maintain NZX compliance and avoid potential trading suspension.